Role of zolpidem as a first-line treatment for insomnia in end-stage kidney disease: A review of efficacy and safety
Pharmacotherapy in Psychiatry and Neurology · 2026
DOI: 10.17219/fpn/237074 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmacotherapy in Psychiatry and Neurology, 2026. Verfasst von Barbara Romanwoska und 9 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).
Themen: Schlaf
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Romanwoska, B., Bilińska, L., Smolarczyk, K., Łukasiewicz, J., Węgrzyn, M., Murawska, A., Jancewicz, M., Błatoń, K., Węgrzyn, G., & Adamczewska, E. (2026). Role of zolpidem as a first-line treatment for insomnia in end-stage kidney disease: A review of efficacy and safety. Pharmacotherapy in Psychiatry and Neurology. https://doi.org/10.17219/fpn/237074
Vancouver
Romanwoska B, Bilińska L, Smolarczyk K, Łukasiewicz J, Węgrzyn M, Murawska A, et al. Role of zolpidem as a first-line treatment for insomnia in end-stage kidney disease: A review of efficacy and safety. Pharmacotherapy in Psychiatry and Neurology. 2026. doi:10.17219/fpn/237074
BibTeX
@article{Romanwoska2026,
author = {Romanwoska, Barbara and Bilińska, Lilianna and Smolarczyk, Konrad and Łukasiewicz, Julia and Węgrzyn, Michał and Murawska, Anastazja and Jancewicz, Marcel and Błatoń, Katarzyna and Węgrzyn, Grzegorz and Adamczewska, Ewelina},
title = {Role of zolpidem as a first-line treatment for insomnia in end-stage kidney disease: A review of efficacy and safety},
journal = {Pharmacotherapy in Psychiatry and Neurology},
year = {2026},
doi = {10.17219/fpn/237074}
}
EUVIMED